WebMar 2, 2024 · BOSTON, March 2, 2024 /PRNewswire/ -- The co-founder of Aldevron, Dr. John Ballantyne, has invested $3M in CureLab Oncology and CureLab Veterinary. The two sister companies have developed an anti-cancer and anti-inflammatory drug that was contract-manufactured by Aldevron at the time Dr. Ballantyne served there as chief … WebSep 9, 2024 · CureLab Oncology Inc. is a pre-IPO, clinical-stage immuno-oncology biotech company headquartered in the greater Boston area, Massachusetts. CureLab is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. To learn more, visit curelab.com. Media contact: Tim Cox, …
Hong Li - Interim Clinical Director - CureLab Oncology ZoomInfo
WebCurrently, CureLab, Inc. is a holding company for CureLab Oncology, Inc. Chief Scientific Officer Feasibility Study Institute Jan 1999 - Nov 2001 2 … WebCureLab family is pursuing a common goal on 4 continents. - Currently conducting international phase II clinical trails - We developed a novel anti-cancer biological agent, which works through two ... northbourne ce primary school
CureLab Oncology Establishes Operations in Europe
WebJan 21, 2024 · About CureLab Oncology. CureLab Oncology Inc. is a clinical-stage immuno-oncology biotech company headquartered in the greater Boston area. CureLab is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. To learn more, visit curelab.com. Media contact: WebBackground. Here we report the first intermediate analysis of a randomized prospective multi-center clinical study aimed to evaluate safety and efficacy of p62/SQTM1-encoding plasmid applied as an adjuvant to chemotherapy in patients with advanced platinum-resistant ovarian cancer. WebJan 21, 2024 · CureLab Oncology Inc. is a clinical-stage immuno-oncology biotech company headquartered in the greater Boston area. CureLab is dedicated to advancing … northbourne chemist shoreham